Coolen; Hein K. A. C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Coolen; Hein K. A. C..The latest application filed is for "spiro-cyclic amine derivatives as s1p modulators".

Company Profile

5.21.17

Coolen; Hein K. A. C. - Hoofddorp NL
Coolen; Hein K. A. C. - Weesp NL
Coolen; Hein K.A.C. - CP Weesp NL
Coolen, Hein K A C - Weesp NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Spiro-cyclic amine derivatives as S1P modulators Grant 11,427,598 - Stoit , et al. August 30, 2	2022-08-30
Spiro-cyclic Amine Derivatives As S1p Modulators App 20210130364 - Stoit; Axel ; et al.	2021-05-06
Fused heterocyclic derivatives as S1P modulators Grant RE48,301 - Smid , et al. November 10, 2	2020-11-10
Spiro-cyclic amine derivatives as S1P modulators Grant 10,807,991 - Stoit , et al. October 20, 2	2020-10-20
Spiro-cyclic Amine Derivatives As S1p Modulators App 20190218227 - Stoit; Axel ; et al.	2019-07-18
Spiro-cyclic amine derivatives as S1P modulators Grant 10,179,791 - Stoit , et al. Ja	2019-01-15
Spiro-cyclic amine derivatives as S1P modulators Grant 9,951,084 - Stoit , et al. April 24, 2	2018-04-24
Fused heterocyclic derivatives as S1P modulators Grant 9,670,220 - Smid , et al. June 6, 2	2017-06-06
Spiro-cyclic Amine Derivatives As S1p Modulators App 20160340363 - Stoit; Axel ; et al.	2016-11-24
(Thio)morpholine derivatives as S1P modulators Grant 9,273,017 - Iwema Bakker , et al. March 1, 2	2016-03-01
Fused Heterocyclic Derivatives As S1p Modulators App 20150284403 - Smid; Pieter ; et al.	2015-10-08
(thio)morpholine Derivatives As S1p Modulators App 20150239857 - Iwema Bakker; Wouter I. ; et al.	2015-08-27
Fused heterocyclic derivatives as S1P modulators Grant 9,096,612 - Smid , et al. August 4, 2	2015-08-04
(Thio)morpholine derivatives as S1P modulators Grant 9,045,441 - Iwema Bakker , et al. June 2, 2	2015-06-02
Fused heterocyclic derivatives as S1P modulators Grant 8,796,262 - Smid , et al. August 5, 2	2014-08-05
Heterocyclic compounds with affinity to muscarinic receptors Grant 8,735,388 - Stoit , et al. May 27, 2	2014-05-27
Heterocyclic Compounds Iwth Affinity To Muscarinic Receptors App 20140080861 - Stoit; Axel ; et al.	2014-03-20
Fused Heterocyclic Derivatives As S1p Modulators App 20140066433 - Smid; Pieter ; et al.	2014-03-06
Heterocyclic compounds with affinity to muscarinic receptors Grant 8,586,606 - Stoit , et al. November 19, 2	2013-11-19
Fused Heterocyclic Derivatives As S1p Modulators App 20130203737 - Smid; Pieter ; et al.	2013-08-08
Spiro-cyclic Amine Derivatives As S1p Modulators App 20130196998 - Stoit; Axel ; et al.	2013-08-01
(thio)morpholine Derivatives As S1p Modulators App 20120220552 - Iwema Bakker; Wouter I. ; et al.	2012-08-30
Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition Grant 8,252,930 - Stoit , et al. August 28, 2	2012-08-28
Heterocyclic Compounds With Affinity To Muscarinic Receptors App 20120095039 - Stoit; Axel ; et al.	2012-04-19
Heterocyclic compounds with affinity to muscarinic receptors Grant 8,084,473 - Stoit , et al. December 27, 2	2011-12-27
Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition Grant 7,964,728 - Stoit , et al. June 21, 2	2011-06-21
Azaindole Derivatives With A Combination Of Partial Nicotinic Acetyl-choline Receptor Agonism And Dopamine Reuptake Inhibition App 20110053962 - Stoit; Axel ; et al.	2011-03-03
Heterocyclic Compounds with Affinity to Muscarinic Receptors App 20090018160 - Stoit; Axel ; et al.	2009-01-15
Azaindole Derivatives With A Combination Of Partial Nicotinic Acetyl-choline Receptor Agonism And Dopamine Reuptake Inhibition App 20080009514 - STOIT; Axel ; et al.	2008-01-10
Diazabicyclo alkane derivatives with NK.sub.1 antagonistic activity Grant 7,202,238 - de Boer , et al. April 10, 2	2007-04-10
Piperazine oxime dervatives having NK-1 receptor antagonistic activity Grant 7,094,779 - Bakker , et al. August 22, 2	2006-08-22
Piperazine oxime dervatives having nk-1 receptor antagonistic activity App 20040176389 - Bakker, Wouter I Ivema ; et al.	2004-09-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.